Salicylic acid nitroalkene (Eolo Pharma)

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameSalicylic acid nitroalkene (Eolo Pharma)
Drug Alias NameMVD1MVD-1SANA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnergy metabolism stimulants
TargetsUpdating
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEolo Pharma Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEolo Pharma Pty Ltd
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A